Biotechnology Patents

Robert Harper harper at finsun.csc.fi
Wed Oct 9 03:29:13 EST 1991


In <9110081649.AA03460 at gcg.com> devereux at GCG.COM writes:

>6) no substantial amount of genome money is going to patenting sequence data
>at this time.  the decision to patent is made by the investigator and her
>institution and costs are normally born by the institution.  because the
>cost is substantial the institution is unlikely to make frivolous
>application. 

**********************  CLIP from New Scientist ********************

New Scientist 7th Sept 1991 No 1785 page 22. 
Title "Genome funds 'wasted' on patents.

Quote:

Walter Bodmer, the president of HUGO, told the BA that American
researchers funded by federal agencies, including the NIH and DOE
are filing patents for some 1000 partial sequences of human genetic 
material each month. With each application costing $30, this amounts
to some $30,000 a month. The initial cost of patenting is double 
the cost of sequencing.

RGDS -=ROB=-


% Robert Harper                   %   HARPER at FINFUN   %   HARPER at CSC.FI   %
% Finnish State Computer Centre   %      Bitnet       %     Internet      %
% Tietotie 6, 02101 Espoo Finland % Tel 358 0 4572076 % Fax 358 0 4572302 %



More information about the Bioforum mailing list